Financial anchor year: FY24. Margin and revenue are as filed for FY24. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY23, the latest filing whose balance sheet reconciled as filed. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in Clewiston, FL. It ran an operating surplus of 5.8% in FY24 on $2.0M of operating revenue. It held 11 days of cash on hand (27th percentile among dialysis facilities on liquidity). Operating margin declined from 13.5% in FY20 to 5.8% in FY24.
Operating margin · FY24
+5.8%
▼ 3.9 pts vs FY23
vs dialysis facilities37th pctl of 7,741
Days cash on hand · FY24
11d
all sources
▼ 0.7 days vs FY23
vs dialysis facilities27th pctl
Total operating revenue · FY24
$2.0M
▲ 0.1 $M vs FY23
vs dialysis facilities28th pctl
Total margin · incl. nonoperating · FY24
+2.8%
▼ 2.1 pts vs FY23
vs dialysis facilities32nd pctl
Where CLEWISTON DIALYSIS CENTER sits among dialysis facilities
Operating margin · FY24 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityCLEWISTON DIALYSISdialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+5.8% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+2.8% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
11d (FY24)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
1.20× (FY23)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
62% (FY23)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
53d (FY23)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
FY23
FY24
Patient revenue
1,807
1,976
2,031
Total operating revenue
1,807
1,976
2,031
Total operating expenses
1,678
1,784
1,914
Operating income
128
192
117
Operating margin %
+7.1%
+9.7%
+5.8%
Other non-operating, net
0
(101)
(62)
Net income
128
91
55
Net income %
+7.1%
+4.9%
+2.8%
HCRIS CMS-265 cost report · $ thousands · FY20–FY24 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Economic context: 12.3% of county personal income is Medicare/Medicaid medical benefits; 28.9% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
